Evidence map›Paper›PMID 39766088›Full record

ReviewCancers2024

Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis.

Apriliana Ellya Ratna Kartikasari, Paul Michel-Lara, Hayden Exton, Kaan Tekin-Sari, Ebtesam Motlaq M Alnefai, Arnan Mitchell, Cesar Sanchez-Huertas, Magdalena Plebanski

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Apriliana Ellya Ratna KartikasariCancer, Ageing, and Vaccine Research Group (CAVA), School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia.ORCID 0000-0002-8115-4866
Paul Michel-LaraIntegrated Photonics and Applications Centre (InPAC), School of Engineering, RMIT University, Melbourne 3001, Australia.ORCID 0009-0006-2888-4532
Hayden ExtonCancer, Ageing, and Vaccine Research Group (CAVA), School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia.
Kaan Tekin-SariCancer, Ageing, and Vaccine Research Group (CAVA), School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia.
Ebtesam Motlaq M AlnefaiCancer, Ageing, and Vaccine Research Group (CAVA), School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia.ORCID 0009-0003-5322-0824
Arnan MitchellIntegrated Photonics and Applications Centre (InPAC), School of Engineering, RMIT University, Melbourne 3001, Australia.
Cesar Sanchez-HuertasIntegrated Photonics and Applications Centre (InPAC), School of Engineering, RMIT University, Melbourne 3001, Australia.ORCID 0000-0002-3100-4034
Magdalena PlebanskiCancer, Ageing, and Vaccine Research Group (CAVA), School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia.ORCID 0000-0001-6889-3667

Funding

National Health and Medical Research Council 2011747
6 · The paper itself

Abstract

Ovarian cancer (OC) is one of the most common gynecological cancers [...].

Indexed as

circulating biomarkerdiagnosismicroRNAsovarian cancerpersonalized therapy

Identifiers

PMID39766088
PMCPMC11674734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.